Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10037757HBVENSG00000132330.18protein_codingSCLYNoNo51540A0A0A0MQU4
B4DDP9
Q96I15
TVIS10040785HBVENSG00000132330.18protein_codingSCLYNoNo51540A0A0A0MQU4
B4DDP9
Q96I15
TVIS30007923HIVENSG00000132330.18protein_codingSCLYNoNo51540A0A0A0MQU4
B4DDP9
Q96I15
TVIS30085109HIVENSG00000132330.18protein_codingSCLYNoNo51540A0A0A0MQU4
B4DDP9
Q96I15
TVIS30052620HIVENSG00000132330.18protein_codingSCLYNoNo51540A0A0A0MQU4
B4DDP9
Q96I15
TVIS30052621HIVENSG00000132330.18protein_codingSCLYNoNo51540A0A0A0MQU4
B4DDP9
Q96I15
TCGA Plot Options
Drug Information
GeneSCLY
DrugBank IDDB00114
Drug NamePyridoxal phosphate
Target IDBE0004605
UniProt IDQ96I15
Regulation Typecofactor
PubMed IDs10592235
CitationsBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationPyridoxals and derivatives
SMILESCC1=NC=C(COP(O)(O)=O)C(C=O)=C1O
PathwaysHistidinemia; 3-Methylglutaconic Aciduria Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); beta-Ketothiolase Deficiency; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Argininosuccinic Aciduria; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Porphyrin Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Taurine and Hypotaurine Metabolism; Catecholamine Biosynthesis; Glycine and Serine Metabolism; Carnitine Synthesis; Tyrosinemia Type 3 (TYRO3); Selenoamino Acid Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Globoid Cell Leukodystrophy; Ammonia Recycling
PharmGKBPA164749650
ChEMBLCHEMBL82202